| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 2.85% | |
| Healthcare | 97.15% |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 42.82 | 0.00 (0.00%) | 28.50 - 43.77 | 0.0 |
Market data as of 3:59PM 05/17/13. Quotes are delayed by at least 15 min.
The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Pharmaceuticals IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. It is non-diversified.
| Open | -- |
|---|---|
| Previous Close | 42.82 |
| Day's Range | -- - -- |
| Avg Volume (10 Day) | 89.9K |
| Total Assets | $468.31M |
| Expense Ratio | 0.64% |
| Yield (Trailing 12 Mo.) | 1.33% |
| Fund Inception | 06/23/2005 |
| Timeframe | PJP | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 3.22% | 1.93% | 3.38% |
| 3 Month | 9.87% | 7.18% | 10.04% |
| Year-to-Date | 17.96% | 12.74% | 17.90% |
| 1 Year | 29.26% | 16.89% | 26.16% |
| 3 Year | 28.95% | 12.80% | 17.80% |
| 5 Year | 20.05% | 5.21% | 13.29% |
| 10 Year | -- | 7.88% | 8.84% |
| Since Inception | 14.63% | 10.38% | -- |
| Basic Materials | 0.00% | |
|---|---|---|
| Consumer Cyclical | 0.00% | |
| Financial Services | 0.00% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 2.85% | |
| Healthcare | 97.15% |
| Utilities | 0.00% | |
|---|---|---|
| Communication Services | 0.00% | |
| Energy | 0.00% | |
| Industrials | 0.00% | |
| Technology | 0.00% |
| Valuation | PJP | Category Range |
|---|---|---|
| Price/Earnings | 20.36 | |
| Price/Book | 3.58 | |
| Price/Sales | 2.93 | |
| Price/Cash Flow | 12.88 | |
| Dividend Yield | 1.48 | |
| LT Earnings | 14.41 | |
| Historical Earnings | 4.25 | |
| Sales Growth | 9.93 | |
| Cash-Flow Growth | 5.63 | |
| Book-Value Growth | 9.52 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
![]() | ![]() | ![]() |

| Rating | vs Category | |
|---|---|---|
| Overall | ![]() ![]() ![]() ![]() ![]() | |
| Risk | Avg | |
| Return | High |
| Beta | 0.67 |
|---|---|
| Standard Deviation | 13.47 |
| Alpha | 19.47 |
| Sharpe Ratio | 1.96 |
| Mean | 29.99 |
| R-Squared | 68.81 |
| Pretax Return | 28.95% |
|---|---|
| Tax-adjusted Return | 28.51% |
| Tax Cost Ratio | 0.34% |
| Potential Cap Gains | 18.24% |